fluorescein-5-isothiocyanate has been researched along with Atrophy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharyya, A; Choudhuri, T; Das, T; Lahiry, L; Mandal, D; Sa, G | 1 |
| Chen, LW; Hsu, CM; Liu, CH | 1 |
| Kasper, RC; LeBoit, PE; Nihal, M; Wood, GS | 1 |
3 other study(ies) available for fluorescein-5-isothiocyanate and Atrophy
| Article | Year |
|---|---|
Failure in peripheral immuno-surveillance due to thymic atrophy: importance of thymocyte maturation and apoptosis in adult tumor-bearer.
Topics: Animals; Annexin A5; Apoptosis; Atrophy; bcl-2-Associated X Protein; Carcinoma, Ehrlich Tumor; CD4-CD8 Ratio; Cell Cycle; DNA; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Genes, bcl-2; Immunologic Surveillance; Longitudinal Studies; Mice; Neoplasm Transplantation; Proto-Oncogene Proteins c-bcl-2; Spleen; T-Lymphocytes; Thymus Gland | 2005 |
Nitric oxide synthase inhibitor ameliorates oral total parenteral nutrition-induced barrier dysfunction.
Topics: Administration, Oral; Animals; Atrophy; Bacterial Translocation; Dextrans; Enzyme Activation; Enzyme Inhibitors; Female; Fluorescein-5-isothiocyanate; Ileum; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Isothiuronium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Parenteral Nutrition, Total; Permeability; Rats; Rats, Sprague-Dawley; Solutions | 2000 |
Anetoderma arising in cutaneous B-cell lymphoproliferative disease.
Topics: Adult; Atrophy; Cutis Laxa; Cyclosporine; DNA; Elastic Tissue; Female; Fluorescein-5-isothiocyanate; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesvirus 4, Human; Humans; Immunocompromised Host; Immunohistochemistry; In Situ Hybridization; Kidney Transplantation; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Lymphoproliferative Disorders; Male; Polymerase Chain Reaction; RNA, Viral; Skin Neoplasms; Tacrolimus | 2001 |